Azitra (AZTR) Operating Leases (2022 - 2026)

Azitra (AZTR) posted Operating Leases of $337480.0 for Q1 2026, up 116.07% on a QoQ basis from $156190.0 in Q4 2025, and down 25.24% year-over-year from $451412.0 in Q1 2025.

Azitra (AZTR) Operating Leases (2022 - 2026) Analysis & Trends

Azitra's Operating Leases history runs 5 years deep, the most recent figure standing at $337480.0 for Q1 2026.

  • Quarterly Operating Leases fell 25.24% year-over-year to $337480.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $337480.0 (down 25.24% YoY) and the FY2025 annual result came in at $156190.0, down 43.03% from the prior year.
  • Operating Leases was $337480.0 for Q1 2026 at Azitra, up from $156190.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $914995.0 in Q3 2023 and bottomed at $156190.0 in Q4 2025.
  • A 5-year average of $519809.4 and a median of $485416.0 in 2025 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2024 — Operating Leases plunged 63.22% — and 2025, when it soared 44.23%.
  • Azitra's Operating Leases stood at $840896.0 in 2022, then sank by 36.08% to $537523.0 in 2023, then slumped by 49.0% to $274161.0 in 2024, then plunged by 43.03% to $156190.0 in 2025, then surged by 116.07% to $337480.0 in 2026.
  • Business Quant data shows AZTR's Operating Leases at $337480.0 in Q1 2026, $156190.0 in Q4 2025, and $485416.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Nanobiotix 1,769.80 Bn 1,769.74 Bn -
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn -
3 BeOne Medicines 473.64 Bn 468.85 Bn 1.35 Bn
4 Vertex Pharmaceuticals 123.74 Bn 116.49 Bn 2.59 Bn
5 Regeneron Pharmaceuticals 71.73 Bn 62.97 Bn 3.31 Bn
6 Belite Bio 62.10 Bn 62.10 Bn -
7 Argenx Se 54.68 Bn 49.49 Bn 1.41 Bn
8 Alnylam Pharmaceuticals 38.13 Bn 35.12 Bn 959.66 Mn
9 Revolution Medicines 36.21 Bn 36.21 Bn -
10 Azitra 2.03 Mn 2.03 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 337,480.00
Dec 31, 2025 156,190.00
Sep 30, 2025 485,416.00
Jun 30, 2025 273,027.00
Mar 31, 2025 451,412.00
Dec 31, 2024 274,161.00
Sep 30, 2024 336,556.00
Jun 30, 2024 689,013.00
Mar 31, 2024 767,244.00
Dec 31, 2023 537,523.00
Sep 30, 2023 914,995.00
Jun 30, 2023 693,609.00
Dec 31, 2022 840,896.00